Project Grant HT94252510965
- This $298,329 federal Project Grant awarded by the Defense Health Agency on March 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Arkansas for Medical Sciences (UAMS) on the role of subchondral bone osteocytes in post-traumatic osteoarthritis. UAMS, a major academic medical center, will leverage its expertise in biomedical research to investigate this specific aspect of osteoarthritis development over the 2-year award...
- The University of Arizona will receive $724,825 through September 2026 under a Project Grant from the Defense Health Agency. The grant supports the development of osseosurface electronics to monitor rehabilitation and accelerate return to duty following surgical treatment of long bone fractures. This award furthers the goals of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative medical research solutions...
- The University of Arizona was awarded a $1,791,407 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on March 1, 2025. The grant will fund research targeting drug resistance in the bone microenvironment using a novel PIM-PROTAC, with an ultimate completion date of February 29, 2028. This research initiative aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
- The University of Arkansas has been awarded a $1,904,960.00 Project Grant from the U.S. Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research and development of a novel wearable sensor device for time-critical hemorrhage monitoring and control. The project aims to make advancements in military medicine through innovative biomedical research with potential to improve health outcomes for service members,...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
- The University of Arkansas at Little Rock (UALR) has been awarded a $5,000,000 Project Grant from the Department of Defense's Basic Scientific Research program (CFDA 12.431). The grant, which began on March 1, 2024, will support foundational and applied research to advance military capabilities across diverse scientific and technical domains, including quantum computing, artificial intelligence, robotics, advanced materials, and defense technologies. UALR, a member of the University of...
- The federal Project Grant award of $749,049 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Northeastern University for the project "ADVANCING OVERLOAD PREDICTION AND PROTECTION IN BONE-ANCHORED LIMBS". The award, with a performance period from June 1, 2025 to May 31, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The...
- The federal Project Grant award of $749,343.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by New York University School of Medicine on a P15-1 Peptide Treatment for Cartilage Injuries and Post-Traumatic Osteoarthritis. This award, with a performance period from August 1, 2025 to July 31, 2027, will fund advanced biomedical research to develop innovative medical solutions that address critical health challenges relevant to...
- The U.S. Defense Health Agency awarded a $792,500.00 Project Grant to Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University-Of The Commonwealth System Of Higher Educa and doing business as Temple University, for the purpose of "AN EFFECTIVE STRATEGY TO PROMOTE AXON REGENERATION AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY". The Project Grant is funded through the U.S. Military Medical Research and Development program (CFDA 12.420),...
This Project Grant award of $4,817,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Arkansas at Little Rock (UALR) in developing a novel biomedical platform for spine bone tissue regeneration. The 3-year project, which commenced on August 15, 2025, aims to advance innovative medical solutions that address critical health challenges relevant to military personnel and the broader public. As a comprehensive research institution, UALR has a strong track record in securing and managing complex federal awards across diverse scientific and technological domains, including previous work with NASA and the Department of Defense. The university's federal grant portfolio demonstrates its integrated approach to biomedical research and development, with a focus on areas such as cybersecurity, materials science, and technological innovation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $4.8m | 8/13/25 |